The researchers in the BREATH research network have contributed significantly to the development of inhalation therapy using Iloprost aerosols, support of combination therapies and the development of guidelines in the field of PH.

The research groups put their expertise into the generation of cardiovascular differentiation and into the scalable expansion of the human induced pluripotent stem cells (iPSC), which is of utmost importance in the development of innovative stem cell therapy.